Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for COVID-19 Prognosis and Treatment
NCT04739345Completed
- Sponsor
- Ain Shams University
- Start
- Dec 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of pentoxifylline in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Ain Shams University. Primary endpoints: Change in patients' clinical status at 2 weeks, Time to increase in oxygenation at 48 hours and 2 more. Started Dec 2020; status: completed.
02
Drugs
pentoxifylline
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04739345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04739345.